ENDRA LIFE SCIENCES INC (NDRA) Stock Price & Overview
NASDAQ:NDRA • US29273B5003
Current stock price
The current stock price of NDRA is 4.69 USD. Today NDRA is up by 0.86%. In the past month the price increased by 36.73%. In the past year, price increased by 32.49%.
NDRA Key Statistics
- Market Cap
- 5.487M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -13.36
- Dividend Yield
- N/A
NDRA Stock Performance
NDRA Stock Chart
NDRA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to NDRA. When comparing the yearly performance of all stocks, NDRA is one of the better performing stocks in the market, outperforming 76.02% of all stocks.
NDRA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NDRA. NDRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
NDRA Earnings
NDRA Forecast & Estimates
7 analysts have analysed NDRA and the average price target is 30.6 USD. This implies a price increase of 552.45% is expected in the next year compared to the current price of 4.69.
NDRA Groups
Sector & Classification
NDRA Financial Highlights
Over the last trailing twelve months NDRA reported a non-GAAP Earnings per Share(EPS) of -13.36. The EPS increased by 98.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -407.68% | ||
| ROE | -4671.65% | ||
| Debt/Equity | 0 |
NDRA Ownership
NDRA Latest News, Press Relases and Analysis
NDRA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 17.91 | 177.903B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.23 | 164.959B | ||
| SYK | STRYKER CORP | 21.92 | 126.058B | ||
| BSX | BOSTON SCIENTIFIC CORP | 17.96 | 92.001B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.9 | 47.196B | ||
| IDXX | IDEXX LABORATORIES INC | 38.42 | 44.958B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 44.516B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.61 | 32.805B | ||
| RMD | RESMED INC | 18.25 | 32.465B | ||
| DXCM | DEXCOM INC | 24.47 | 24.004B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.81B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.877B | ||
| PODD | INSULET CORP | 31.6 | 14.576B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NDRA
Company Profile
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
Company Info
IPO: 2017-06-28
ENDRA LIFE SCIENCES INC
3600 Green Ct Ste 350
Ann Arbor MICHIGAN 48105 US
CEO: Francois Michelon
Employees: 21
Phone: 17343350468
ENDRA LIFE SCIENCES INC / NDRA FAQ
What does NDRA do?
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. TAEUS is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools. TAEUS technology uses a pulsed energy source, specifically, radio frequency (RF), to transmit energy deep into tissue and generate ultrasonic waves based on the tissue composition (or tissue chemistry), differentiating lean and fatty tissues. These waves are then detected with ultrasound sensors at the skin surface and used to create high-contrast images using its proprietary algorithms.
What is the current price of NDRA stock?
The current stock price of NDRA is 4.69 USD. The price increased by 0.86% in the last trading session.
Does ENDRA LIFE SCIENCES INC pay dividends?
NDRA does not pay a dividend.
What is the ChartMill technical and fundamental rating of NDRA stock?
NDRA has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists NDRA stock?
NDRA stock is listed on the Nasdaq exchange.
Can you provide the market cap for ENDRA LIFE SCIENCES INC?
ENDRA LIFE SCIENCES INC (NDRA) has a market capitalization of 5.49M USD. This makes NDRA a Nano Cap stock.